ComplianceQuest Support of Compliance to FDA 21 CFR Part 11Requirements WHITE PAPER. ComplianceQuest In-Depth Analysis and Review

Similar documents
OpenLAB ELN Supporting 21 CFR Part 11 Compliance

Compliance Matrix for 21 CFR Part 11: Electronic Records

Adobe Sign and 21 CFR Part 11

COMPLIANCE. associates VALIDATOR WHITE PAPER. Addressing 21 cfr Part 11

TECHNICAL BULLETIN [ 1 / 13 ]

SDA COMPLIANCE SOFTWARE For Agilent ICP-MS MassHunter Software

Exhibitor Software and 21 CFR Part 11

FDA 21 CFR Part 11 Compliance by Metrohm Raman

Integration of Agilent UV-Visible ChemStation with OpenLAB ECM

Agilent ICP-MS ChemStation Complying with 21 CFR Part 11. Application Note. Overview

21 CFR Part 11 LIMS Requirements Electronic signatures and records

ChromQuest 5.0. Tools to Aid in 21 CFR Part 11 Compliance. Introduction. General Overview. General Considerations

ISSUE N 1 MAJOR MODIFICATIONS. Version Changes Related Release No. PREVIOUS VERSIONS HISTORY. Version Date History Related Release No.

21 CFR PART 11 COMPLIANCE

Integration of Agilent OpenLAB CDS EZChrom Edition with OpenLAB ECM Compliance with 21 CFR Part 11

NucleoCounter NC-200, NucleoView NC-200 Software and Code of Federal Regulation 21 Part 11; Electronic Records, Electronic Signatures (21 CFR Part 11)

21 CFR Part 11 FAQ (Frequently Asked Questions)

21 CFR Part 11 Module Design

The Impact of 21 CFR Part 11 on Product Development

Sparta Systems TrackWise Digital Solution

Validation Checklist Appendix A WiZARD2 Secure and 21 CFR 11 Requirements

Compliance of Shimadzu Total Organic Carbon (TOC) Analyzer with FDA 21 CFR Part 11 Regulations on Electronic Records and Electronic Signatures

System Assessment Report Relating to Electronic Records and Electronic Signatures; 21 CFR Part 11. System: StabNet (Software Version 1.

WHITE PAPER AGILOFT COMPLIANCE WITH CFR 21 PART 11

Agilent Response to 21CFR Part11 requirements for the Agilent ChemStation Plus

System Assessment Report Relating to Electronic Records and Electronic Signatures; 21 CFR Part 11. System: tiamo (Software Version 2.

Sparta Systems TrackWise Solution

Metrohm White paper. FDA 21 CFR Part 11 Requirements for NIR Spectroscopy. Dr. N. Rühl

Sparta Systems Stratas Solution

System Assessment Report Relating to Electronic Records and Electronic Signatures; Final Rule, 21 CFR Part 11

REGULATION ASPECTS 21 CFR PART11. 57, av. Général de Croutte TOULOUSE (FRANCE) (0) Fax +33 (0)

Part 11 Compliance SOP

INFORMATION. Guidance on the use of the SM1000 and SM2000 Videographic Recorders for Electronic Record Keeping in FDA Approved Processes

EZChrom Elite Chromatography Data System. Regulatory Compliance with FDA Rule of Electronic Records and Electronic Signatures (21 CFR Part 11)

Introduction. So what is 21 CFR Part 11? Who Should Comply with 21CFR Part 11?

System Assessment Report Relating to Electronic Records and Electronic Signatures; Final Rule, 21 CFR Part 11. System: tiamo 2.3

Introduction 2. History. Adapted to zenon version 6.20 (MH) January 13 th, 2006

21 CFR PART 11 FREQUENTLY ASKED QUESTIONS (FAQS)

Electronic Records and Signatures with the Sievers M9 TOC Analyzer and DataPro2 Software

Using "IC Net 2.2 " software to comply with 21 CFR Part 11

Electronic Data Processing 21 CFR Part 11

Using "TiNet 2.5 Compliant SR1" software to comply with 21 CFR Part 11

Guidelines for applying FactoryTalk View SE in a 21 CFR Part 11 environment

White Paper Assessment of Veriteq viewlinc Environmental Monitoring System Compliance to 21 CFR Part 11Requirements

Assessment of Vaisala Veriteq viewlinc Continuous Monitoring System Compliance to 21 CFR Part 11 Requirements

Technical Information

Using the Titrando system to comply with 21 CFR Part 11

Real World Examples for Part 11 Technical Controls

Using Chromeleon Chromatography Management Software to Comply with 21 CFR Part 11

Agilent Technologies Dissolution Workstation Software Electronic Records and Data Storage Background

Automation Change Management for Regulated Industries

Spectroscopy Configuration Manager (SCM) Software. 21 CFR Part 11 Compliance Booklet

21 CFR 11 Assistant Software. 21 CFR Part 11 Compliance Booklet

Using Chromeleon 7 Chromatography Data System to Comply with 21 CFR Part 11

An Easy to Understand Guide 21 CFR Part 11

Meeting regulatory compliance guidelines with Agilent ICP-MS MassHunter and OpenLAB Server

Cell Therapy Data Management

MicroLab FTIR Software 21 CFR Part 11 Compliance

Complying with FDA's 21 CFR Part 11 Regulation

21 CFR Part 11 Fundamentals

EU Annex 11 Compliance Regulatory Conformity of eve

eprost System Policies & Procedures

How to get your Movicon 11 project FDA 21 CFR Part 11 ready. Document: RAC-4105 Released: Updated: Rel. Movicon: 11.

System Assessment Report Relating to Electronic Records and Electronic Signatures; Final Rule, 21 CFR Part 11. System: tiamo 2.0

Achieving 21 CFR Part11 Compliance using Exaquantum/Batch Authored by Stelex

Premium HMI and FDA 21 Part 11 regulations TN0009. Version Description Date 1 First emission 10/04/2012

Pharma IT ELECTRONIC RECORDS

Statement of 21 CFR Part 11 Validation Results

ABB Limited. Table of Content. Executive Summary

Using the Titrando system to comply with 21 CFR Part 11

OM-MICROLITE-8 AND OM- MICROLITE-16 DATA LOGGERS AND OM-MICROLAB

testo Comfort Software CFR 4 Instruction manual

Chapter 9 Section 3. Digital Imaging (Scanned) And Electronic (Born-Digital) Records Process And Formats

A Quick Guide to EPCS. What You Need to Know to Implement Electronic Prescriptions for Controlled Substances

Achieving 21 CFR Part 11 Compliance using CENTUM VP

Guidance for a 21 CFR Part 11 implementation on Microsoft Office SharePoint Server 2007

WHITE PAPER PAPERWISE DOCUMENT MANAGEMENT COMPLIANCE WITH SEC 17A-4

Access to University Data Policy

Guide for 21 CFR part 11 on NucleoView NC-200

Electronic Signature Policy

90% 191 Security Best Practices. Blades. 52 Regulatory Requirements. Compliance Report PCI DSS 2.0. related to this regulation

Implementing an Audit Program for HIPAA Compliance

Summary. Implementing CFR21 Part 11 with Movicon 11 Page 2

Achieving 21 CFR Part 11 Compliance using CENTUM VP

General Data Protection Regulation (GDPR) and the Implications for IT Service Management

ISO/IEC INTERNATIONAL STANDARD. Information technology Security techniques Biometric information protection

Electronic and digital signatures in Adobe Sign for government.

Use of data processor (external business unit)

Forms. GDPR for Zoho Forms

MARPA DOCUMENT MARPA Revision 1.1

How WhereScape Data Automation Ensures You Are GDPR Compliant

RECORDS AND INFORMATION MANAGEMENT AND RETENTION

ORA HIPAA Security. All Affiliate Research Policy Subject: HIPAA Security File Under: For Researchers

Supersedes: S-EG-06. Specifications relating to event loggers for electricity and gas metering devices

PR GB. 21 CFR part 11 Compliance

Policy. Sensitive Information. Credit Card, Social Security, Employee, and Customer Data Version 3.4

CERTIFIED MAIL LABELS TERMS OF USE and PRIVACY POLICY Agreement

YOUR GUIDE TO I-STOP COMPLIANCE AND EPCS

Implementing Electronic Signature Solutions 11/10/2015

Learning Management System - Privacy Policy

Transcription:

ComplianceQuest Support of Compliance to FDA 21 CFR Part 11 WHITE PAPER ComplianceQuest In-Depth Analysis and Review

ComplianceQuest Support of Compliance to FDA is the FDA guideline that defines the criteria under which electronic records and electronic signatures are considered to be dependable, reliable and equivalent to that of the paper records. Part 11, as it is commonly known, was introduced in 1997 and applies to the FDA-governed industries that choose to store their primary, authoritative records electronically. It stipulates the guidelines and rules for storage, copying, access & permissions, audit logs & tracking. It also identifies version control of the electronic records and the application of electronic signatures to them. Part 11 applies to all records that are defined in the underlying Acts and Regulations which govern activities in the life science industries. Part 11 requires drug makers, medical device manufacturers, biotech companies, biologics developers, and other FDA-regulated industries to implement controls, including: audits, system validations, audit trails, electronic signatures, & documentation for software and systems involved in processing electronic data that are either required to be maintained by the FDA predicate rules or used to demonstrate compliance to a predicate rule. ComplianceQuest (CQ) supports FDA compliance requirements for life science organizations in health-care, pharmaceutical, life-science, biotechnology, medical-manufacturing, medical-device, and other FDAregulated industries. Title requires companies to implement controls, including audits, system validations, audit trails, electronic signatures, and documentation for software and systems that are involved in processing many forms of data, as part of their business practices and product development. Title enacted the FDA's requirement that they be able to recognize electronic records and electronic signatures as dependable, reliable, and legal equivalents to paper records and handwritten signatures. This also allows companies to go to a paperless system of record keeping.

Electronic Signature CQ automatically secures and binds the authenticated user's electronic signature. CQ ensures that the user has signed onto the system and exposed their signature through the forced authentication process, as required by 21 CFR Part 11. Authentication is required each time a transaction is processed. It is equivalent to that of a paper form that would have been signed by an individual. Audit Trail CQ securely and automatically posts any and all field changes to a separate database. The Audit Trail includes the field's old value, new value, name of the user who made the change, and date and time. CQ not only stores the audit trail information, but also allows for the information to be queried and helps present the information to support a regulatory audit easily. Comparison of System Requirement with ComplianceQuest Features 11.10b The system shall generate accurate and complete copies of records in human readable and electronic form suitable for inspection, review and copying 11.10d The system shall limit access to authorized individuals. 11.10e The system shall employ secure, computergenerated date/time stamped audit trails to independently record CQ has a broad range of standard reports and ability to generate custom reports, in both printed and downloadable electronic formats. CQ access is controlled by user id and password. Access to different functions and scope of data accessed is controlled by Function Permissions to role with Function Data Scope tables. These permissions and data scoping rules and may be customized. CQ database audit-trail tables (Insert, Update, and Delete triggers) exist for all the transaction records.

operator entries and actions that create, modify, or delete electronic records, without obscuring previously recorded information. 11.10f The system shall enforce required steps and events sequencing, as appropriate (e.g., key steps cannot be bypassed or similarly compromised). 11.10g that only authorized individuals can use the system. Electronically sign a record, access the operations or computer system input or output device, alter a record, or perform the operation at hand. 11.10h The system shall determine, as appropriate, the validity of the source of data input or operational instruction. 11.50, (2), (3) all signed electronic records contain the printed name of the signer, date/time signature was executed, and the meaning associated with the signature (e.g. approval, responsibility, CQ system provides for the full enforcement of the pre-defined and validated rules that ensures that the required steps and event sequencing are performed as specified. CQ access is controlled by a user ID and password. Access to different functions and scope of data accessed is controlled by Function Permissions to Role and Function Data Scope tables. These permissions and data scoping rules may be customized. CQ access is controlled by user ID and password. Users may be required to reinput their password when approving a SCAR or confirming a change. CQ stores the user ID of the signer along with the date/time that the signature was executed. The definition of the signature is also stored in the database.

11.50 (b) 11.70 (a) 11.100 (a) (a) 1 (i) a authorship). the three signature elements (described in the previous requirement) of a signed electronic record, part of a readable form of the electronic record (e.g. electronic display or printout). electronic signatures are linked to their respective electronic records. These electronic signatures cannot be excised, copied, or otherwise transferred to falsify an electronic record by any ordinary means. that each electronic signature is unique to one individual and shall not be reused by, or reassigned to, anyone else. The system shall employee at least two distinct identification components such as an identification code and a password. The system requires the use of all electronic signature components for the first signing during The three signature items are included in all audit trail reports in the CQ solution. The addition of user ID s and date stamps to various records is done automatically by the CQ, rather than through any user interface. CQ User ID s in the system apply to one and only one person. However, it is a procedure to not change the name and property information associated with a user id, other than to correct errors or update information (e.g. address, phone, etc.), as required. If the user ID itself is changed, the changes are propagated to all records in the system with that user ID. The CQ system uses a user ID and a password for access. In the CQ system, the first signing is when the administrator or other user logs into the system. This requires a user ID and password.

(i) b (i) c (ii) (a) (2) (a) (3) a single continuous period of controlled system access The system shall allow all subsequent signing during the same continuous period of controlled system access to use at least one electronic signature component. users are timed out during periods of specified inactivity the use of all electronic signature components for the signings not executed during a single continuous period of controlled system access. non-biometric electronic signatures that can only be used by their genuine owner. all attempted uses of an individual's electronic signature by anyone other than its genuine As confirmation of data inputs or approvals, the CQ will prompt for the at least the password to comply with this requirement. The CQ has a configurable time-out period. If there is no activity for that length of time, the user is logged off and must perform a complete login to re-access the system. In CQ, a single continuous period means the time between login and logout. The logout would either be explicit or based on a timeout as described above. In both cases, a full login is then required, with both a user ID and password. The CQ requires the use of user ID and password for identification. The implementation of this requirement is more procedural, in that user ID s and passwords should be protected and not shared. The password may be configured to be of a certain length and format, and to be changed every nn days. At this time the system does not offer biometric electronic signatures but they can be added on a custom basis. User ID s and passwords should not be shared, and procedures should be in place to ensure this.

11.300 (a) 11.300 (b) owner who will require collaboration of two or more individuals. each combination of identification code and password which is unique, such that no two individuals have the same combination of identification code and password. that passwords be periodically revised. For CQ, the user ID is primary key in the database, and as such, it is impossible to apply it to different users. The CQ can require that passwords be changed every nn days. An audit trail is also kept of password changes. Disclaimer: As per the regulation, the responsibility for FDA compliance falls squarely on companies themselves. They must have appropriate policies, procedures, and technical controls in place, to be compliant, so merely purchasing a software system with compliant functionality does not itself satisfy compliance regulations. While CQ solution has attempted to consider all parts of the Part 11 rule contained in this web page, the system described has not been approved or mandated by FDA or any other governmental agency. ComplianceQuest makes no claims that following the advice herein described will disqualify companies or individuals from FDA sanction. Compliance to FDA regulations in its entirety lies with the using company. About ComplianceQuest: ComplianceQuest, an innovative 100% cloud based Enterprise Quality Management System solution company, provides an enterprise grade solution platform that streamlines quality, compliance, content and collaboration management initiatives and strategies across your enterprise and globally based supply chain networks. ComplianceQuest helps accelerate manufacturers and distributors to accomplishing their most challenging quality, compliance and supplier management goals. ComplianceQuest, 2014 http://compliancequest.com/